Trends in rates of incidence, fatality and antimicrobial resistance among isolates of Pseudomonas spp. causing bloodstream infections in England between 2009 and 2018: results from a national voluntary surveillance scheme-Reference-Cited by-同舟云学术

Trends in rates of incidence, fatality and antimicrobial resistance among isolates of Pseudomonas spp. causing bloodstream infections in England between 2009 and 2018: results from a national voluntary surveillance scheme

Published:2022-02 Issue: Volume:120 Page:73-80
ISSN:0195-6701
Container-title:Journal of Hospital Infection
language:en
Short-container-title:Journal of Hospital Infection

Author:

Gerver S.M.,Nsonwu O.,Thelwall S.,Brown C.S.,Hope R.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference26 articles.

1. Antibiotic resistance rates for Pseudomonas aeruginosa clinical respiratory and bloodstream isolates among the Veterans Affairs Healthcare System from 2009 to 2013;Appaneal;Diagn Microbiol Infect Dis,2018

2. An outbreak of multidrug-resistant Pseudomonas aeruginosa in a burns service in the North of England: challenges of infection prevention and control in a complex setting;Decraene;J Hosp Infect,2018

3. Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates;Cabot;Antimicrob Agents Chemother,2016

4. Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome;Dantas;J Med Microbiol,2014

5. Laboratory Surveillance of Polymicrobial Bacteraemia and Fungaemia in England;Wales and Northern Ireland,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007–22);The Lancet Infectious Diseases;2024-08

2. AAV-vectored expression of monospecific or bispecific monoclonal antibodies protects mice from lethal Pseudomonas aeruginosa pneumonia;Gene Therapy;2024-04-27

3. The Hidden Cost of COVID-19: Focus on Antimicrobial Resistance in Bloodstream Infections;Microorganisms;2023-05-16

4. Research on Antimicrobial Utilization and Resistance in England 2021–22 (ESPAUR Report);ESPAUR 2022;2023-03-28

5. Trends in Pseudomonas aeruginosa (P. aeruginosa) Bacteremia during the COVID-19 Pandemic: A Systematic Review;Antibiotics;2023-02-18